American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 438-447 , March 2009

Albuminuria, Cognitive Functioning, and White Matter Hyperintensities in Homebound Elders

  • Daniel E. Weiner, MD, MS

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Daniel E. Weiner, MD, MS, Division of Nephrology, Box #391, Tufts Medical Center, 800 Washington St, Boston, MA 02111
  • ,
  • Keith Bartolomei, MD

      Affiliations

    • Division of Medicine, Tufts Medical Center, Boston, MA
  • ,
  • Tammy Scott, PhD

      Affiliations

    • Division of Psychiatry, Tufts Medical Center, Boston, MA
  • ,
  • Lori Lyn Price, MS

      Affiliations

    • Biostatistics Research Center, Tufts Medical Center, Boston, MA
  • ,
  • John L. Griffith, PhD

      Affiliations

    • Biostatistics Research Center, Tufts Medical Center, Boston, MA
  • ,
  • Irwin Rosenberg, MD

      Affiliations

    • Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA
  • ,
  • Andrew S. Levey, MD

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA
  • ,
  • Marshal F. Folstein, MD

      Affiliations

    • Division of Psychiatry, Tufts Medical Center, Boston, MA
  • ,
  • Mark J. Sarnak, MD, MS

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA

Received 27 May 2008 ,Accepted 15 August 2008.

References 

  1. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426–436
  2. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease (The Nun Study). JAMA. 1997;277:813–817
  3. Pereira AA, Weiner DE, Scott T, et al. Subcortical cognitive impairment in dialysis patients. Hemodial Int. 2007;11:309–314
  4. Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67:216–223
  5. Fazekas G, Fazekas F, Schmidt R, et al. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci. 1995;134:83–88
  6. Kim CD, Lee HJ, Kim DJ, et al. High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis. 2007;50:98–107
  7. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: The Health, Aging, and Body Composition Study. J Am Soc Nephrol. 2005;16:2127–2133
  8. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004;15:1904–1911
  9. Khatri M, Wright CB, Nickolas TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume: The Northern Manhattan Study (NOMAS). Stroke. 2007;38:3121–3126
  10. Seliger SL, Longstreth WT, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005;16:3721–3727
  11. Kurella-Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: The REGARDS Study. Am J Kidney Dis. 2008;52:227–234
  12. Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: Exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392–401
  13. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  14. Yuyun MF, Khaw KT, Luben R, et al. Microalbuminuria and stroke in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med. 2004;255:247–256
  15. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782
  16. Kuo HK, Lin LY, Yu YH. Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: Results from the U.S. National Health and Nutrition Examination Survey 1999-2002. J Intern Med. 2007;262:562–570
  17. Scott TM, Peter I, Tucker KL, et al. The Nutrition, Aging, and Memory in Elders (NAME) Study: Design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry. 2006;21:519–528
  18. Miller WG, Myers GL, Ashwood ER, et al. Creatinine measurement: State of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med. 2005;129:297–304
  19. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–772
  20. Seshadri S, DeStefano AL, Au R, et al. Genetic correlates of brain aging on MRI and cognitive test measures: A genome-wide association and linkage analysis in the Framingham Study. BMC Med Genet. 2007;8(suppl 1):S15
  21. Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: Part 2. Arch Neurol. 2003;60:1394–1399
  22. Yue NC, Arnold AM, Longstreth WT, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: Data from the Cardiovascular Health Study. Radiology. 1997;202:33–39
  23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  24. Chumlea WC, Roche AF, Steinbaugh ML. Estimating stature from knee height for persons 60 to 90 years of age. J Am Geriatr Soc. 1985;33:116–120
  25. Desmond DW. The neuropsychology of vascular cognitive impairment: Is there a specific cognitive deficit?. J Neurol Sci. 2004;226:3–7
  26. Roman GC. Vascular dementia: Distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc. 2003;51(suppl dementia):S296–S304
  27. Castro A, Coresh J: CKD surveillance using laboratory data and population-based surveys (NHANES). Am J Kidney Dis 2008 (suppl 1) (in press)
  28. Kramer H, Jacobs DR, Bild D, et al. Urine albumin excretion and subclinical cardiovascular disease (The Multi-Ethnic Study of Atherosclerosis). Hypertension. 2005;46:38–43
  29. Wachtell K, Ibsen H, Olsen MH, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Ann Intern Med. 2003;139:901–906
  30. Barzilay JI, Fitzpatrick AL, Luchsinger J, et al. Albuminuria and dementia in the elderly: A community study. Am J Kidney Dis. 2008;52:216–226
  31. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  32. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study (The Nord-Trondelag Health Study (HUNT), Norway). Am J Kidney Dis. 2003;42:466–473

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Katherine Tuttle, MD, Sacred Heart Medical Center) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

 Originally published online as doi:10.1053/j.ajkd.2008.08.022 on December 15, 2008.

PII: S0272-6386(08)01351-6

doi: 10.1053/j.ajkd.2008.08.022

American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 438-447 , March 2009